Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients: A Prospective, Randomized Placebo-controlled Double Blind Trial

NCT02976246 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT02976246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02976246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients: A Prospective, Randomized Placebo-controlled Double Blind Trial
Lead sponsor
Zealand University Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2016
Completion date
Not reported
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone disease, cardiovascular disease, endstage renal disease, vitamin k supplementation